Pathology Report Assessment
This is an excellent and complete hysterectomy pathology report that meets current guideline standards for endometrial carcinoma surgical staging. 1, 2
Key Strengths of This Report
Complete Specimen Documentation
The report appropriately documents all required components for FIGO grade 1 endometrioid adenocarcinoma staging:
- Total hysterectomy with bilateral salpingo-oophorectomy - the standard surgical procedure for stage I disease 1, 2
- Sentinel lymph node biopsy - 3 sentinel lymph nodes examined (1 left pelvic, 2 right pelvic), all negative for malignancy, which is the preferred staging approach per current guidelines 1
- Complete pathologic examination - entire endometrium submitted for histologic review, which is critical given the 15-18% risk of grade upgrading from biopsy to final pathology 3, 4
Appropriate Synoptic Reporting
The report includes a structured synoptic format addressing:
- Histologic type: No residual tumor identified (complete pathologic response)
- Myometrial invasion: Not identified
- Specimen integrity: Intact (avoiding tumor spillage/morcellation as required) 1
- Lymph node status: 0/3 nodes positive
- Additional findings: Adenomyosis, atrophic endometrium, benign ovarian and tubal findings
Critical Clinical Context
The comment section appropriately references the original outside biopsy diagnosis and confirms complete examination of the endometrium with no residual disease identified.
Important Clinical Implications
The finding of no residual adenocarcinoma after complete endometrial sampling is not uncommon - this can occur when the diagnostic curettage removes all tumor, particularly in superficial grade 1 lesions. This does not invalidate the original diagnosis or change management.
Risk Stratification Considerations
- No myometrial invasion identified
- Negative lymph nodes (0/3)
- No lymphovascular space invasion mentioned
- Grade 1 on original biopsy
This patient would be classified as low-risk (FIGO 2023 stage IA1 or IA2) with an estimated 5-year recurrence risk <8% 1
Minor Considerations
The report does not explicitly mention:
- Lymphovascular space invasion status - should be explicitly stated as present or absent
- Cervical stromal invasion - stated as "no significant histopathologic changes" but could be more explicit
- Peritoneal cytology - not mentioned (FIGO/AJCC recommend collection and recording, though not affecting staging) 2
However, these omissions are minor and do not significantly detract from an otherwise comprehensive report. The statement "negative for atypia or malignancy" in the cervix section adequately addresses cervical involvement.
Bottom Line
This pathology report is appropriate, complete, and provides all necessary information for accurate staging, risk stratification, and treatment planning for this patient with FIGO grade 1 endometrioid adenocarcinoma. The surgical approach with sentinel lymph node mapping rather than complete lymphadenectomy aligns with current best practices and reduces surgical morbidity while maintaining staging accuracy 1, 2.